These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17359224)

  • 1. PET tracer technology for monitoring focal epilepsies.
    Koepp MJ
    Expert Rev Med Devices; 2007 Mar; 4(2):191-200. PubMed ID: 17359224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of positron emission tomography with [18F]fluorodeoxyglucose in the evaluation of the epilepsies.
    Henry TR; Votaw JR
    Neuroimaging Clin N Am; 2004 Aug; 14(3):517-35, ix. PubMed ID: 15324862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography in partial epilepsies: the clinical point of view.
    Koutroumanidis M; Binnie CD; Panayiotopoulos CP
    Nucl Med Commun; 1998 Dec; 19(12):1123-6. PubMed ID: 9885801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronuclear assessment of patients with epilepsy.
    Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
    Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of PET in presurgical assessment of partial epilepsies.
    Mauguière F; Ryvlin P
    Epileptic Disord; 2004 Sep; 6(3):193-215. PubMed ID: 15544990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral glucose utilization measured with high resolution positron emission tomography in epileptic Finnish Spitz dogs and healthy dogs.
    Viitmaa R; Haaparanta-Solin M; Snellman M; Cizinauskas S; Orro T; Kuusela E; Johansson J; Viljanen T; Jokinen TS; Bergamasco L; Metsähonkala L
    Vet Radiol Ultrasound; 2014; 55(4):453-61. PubMed ID: 24547764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain abnormalities detected on whole-body 18F-FDG PET in cancer patients: spectrum of findings.
    Stubbs E; Kraas J; Morton KA; Clark PB
    AJR Am J Roentgenol; 2007 Mar; 188(3):866-73. PubMed ID: 17312080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal of blood volume-corrected model for quantification of regional cerebral blood flow with H2 15O-PET and its application to AVF.
    Seki C; Momose T; Kojima Y; Sasaki Y; Ohtomo K; Yokoyama I
    Radiat Med; 2006 May; 24(4):260-8. PubMed ID: 16958399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preoperative localization diagnosis in focal epilepsy using PET].
    Hajek M; Leenders KL; Wieser HG
    Radiologe; 1992 Jun; 32(6):276-81. PubMed ID: 1641485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whiskers area as extracerebral reference tissue for quantification of rat brain metabolism using (18)F-FDG PET: application to focal cerebral ischemia.
    Backes H; Walberer M; Endepols H; Neumaier B; Graf R; Wienhard K; Mies G
    J Nucl Med; 2011 Aug; 52(8):1252-60. PubMed ID: 21764786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET studies in epilepsy.
    Decoo D; Destée A
    Acta Neurol Belg; 1997 Sep; 97(3):196-9. PubMed ID: 9345593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification in positron emission tomography for research in pharmacology and drug development.
    Cunningham VJ; Gunn RN; Matthews JC
    Nucl Med Commun; 2004 Jul; 25(7):643-6. PubMed ID: 15208489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular positron emission tomography and PET/CT imaging in urological malignancies.
    Powles T; Murray I; Brock C; Oliver T; Avril N
    Eur Urol; 2007 Jun; 51(6):1511-20; discussion 1520-1. PubMed ID: 17275167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18 FDG and F-18 FDOPA PET brain imaging in subacute sclerosing panencephalitis.
    Hsieh HJ; Lin SH; Chu YK; Chang CP; Wang SJ
    Clin Nucl Med; 2005 Jul; 30(7):519-20. PubMed ID: 15965337
    [No Abstract]   [Full Text] [Related]  

  • 16. The prognostic value of [F]FDG-PET in nonrefractory partial epilepsy.
    Weitemeyer L; Kellinghaus C; Weckesser M; Matheja P; Loddenkemper T; Schuierer G; Schober O; Ringelstein EB; Lüdemann P
    Epilepsia; 2005 Oct; 46(10):1654-60. PubMed ID: 16190939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous water activation and glucose metabolic rate imaging with PET.
    Verhaeghe J; Reader AJ
    Phys Med Biol; 2013 Feb; 58(3):393-411. PubMed ID: 23296197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Positron emission tomography: which indications, which benefits?].
    Chassoux F; Chiron C
    Neurochirurgie; 2008 May; 54(3):219-25. PubMed ID: 18430441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging of subclinical seizure associated with intracranial cavernous malformations.
    Healy GM; Redmond CE; Kinsella J; Killeen RP
    QJM; 2017 Jan; 110(1):45-46. PubMed ID: 27803370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in evaluation of primary brain tumors.
    Chen W; Silverman DH
    Semin Nucl Med; 2008 Jul; 38(4):240-50. PubMed ID: 18514080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.